维普中文期刊产品整合服务
17篇 您的检索式:作者名="BRIGNONE C"
    题名 作者 年代 出处 被引量
1A phase I pharmaeoki- netic and biological eorrelative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma显示文摘Brignone C Escudier B Grygar C 2009Clin Cancer Res2009,15,19:1
2Polyubiquitination of p53 by a ubiquitin ligase activity of p300显示文摘Grossman S R Deato M E Brignone C 2003Science2003,300,5617:1
3Venous lower-limb evalu- ation in patients with acute pulmonary embolism显示文摘Pomero F Brignone C Serraino C 2011South Med J2011,104,6:1
4Two-dimensional gelanalysis of the proteome of lager brewing yeasts显示文摘Joubert R Brignon P Lehmann C 2000Yeast2000,16,6:1
5Polyubiquitination of p53 by a ubiquitin ligase activity of p300 显示文摘Grossman SR Deato ME Brignone C 2003Science2003,300,5617:1
6A soluble LA G23 protein as an immunopotentiator for therapeutic vaccines:preclinical evaluation of IMP321显示文摘FOU GERA Y S BRIGNONE C TRIEBEL F 2006Vaccine2006,24,:1
7Antibody-mediated depletionof lymphocyte-activation gene-3 (LAG-3 (+) )-activated T lympho-cytes prevents delayed-type hypersensitivity in non-human primates显示文摘Poirier N Haudebourg T Brignone C 2011Clin Exp Immunol2011,164,2:1
8A soluble LAG-3 protein as an immunopotentiator for ther-apertic vaccines:preclinical evaluation of IMP321显示文摘Fougeray S Brignone C Triebel F 0,,26:1
9Polyubiquitination of p53 by a ubiquitin ligase activity of p300显示文摘Grossman SR Deato ME Brignone C 2003Science2003,300,5617:1
10A phase Ipharmacokinetic and biological correlative study of IMP321,a novel MHC class II agonist, in patients with advancedrenal cell carcinoma 显示文摘Brignone C Escudier B Grygar C 2009Clin Cancer Res2009,15,19:1
11A soluble LAG 23 protein as an immun0Potentiator for therapeutic vaccines : preelini- cal evaluation of IMP321' 显示文摘FOU GERA Y S BRIGNONE C TRIEBEL F 2006Vaccine2006,24,9:1
12First-line chemoimmuno- therapy in metastatic breast carcinoma:combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitu- mor activity显示文摘Brignone C Gutierrez M Mefti F 2010J Transl Med2010,23,:1
13Polyubiquitination of p53 by an ubiquitin ligase activity of p300显示文摘Grossman S R Deato M E Brignone C 2003Science2003,300,:1
14A soluble LAG-3 protein as an immunopotentiator for ther apeutic vaccines: preclinical evaluation of IMP321显示文摘FOUGERAY S BRIGNONE C TRIEBEL F 2006Vaccine2006,24,:1
15A soluble LAG-3protein as an immunopotentiator for therapeutic vaccines :Preclinical evaluation of IMP321 显示文摘Fougeray S Brignone C Triebel F 2006Vaccine2006,24,26:1
16Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder 显示文摘Brignone M Diamand F Painchault C 2016Curr Med Res Opin2016,32,2:1
17First-line chemoimmunotherapy in metastatic breast carcinoma: Combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity 显示文摘Brignone C Gutierrez M Mefti F 2010J Transl Med2010,8,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费